Table 2 Baseline quality of life scores stratified by prior treatment history
From: Prognostic value of changes in quality of life scores in prostate cancer
Baseline variable | Newly diagnosed | Previously treated | P |
|---|---|---|---|
(N = 149) | (N = 101) | ||
Mean (standard deviation) | Mean (standard deviation) | ||
General quality of life | |||
Global | 70.7 (23.6) | 58.4 (27.1) | <0.001* |
General function | |||
Physical | 88.5 (17.9) | 79.0 (23.2) | <0.001* |
Role | 86.9 (24.5) | 74.0 (31.3) | <0.001* |
Emotional | 77.0 (22.7) | 70.7 (24.2) | 0.04* |
Cognitive | 85.3 (21.4) | 79.2 (22.6) | 0.03* |
Social | 85.1 (24.2) | 73.1 (29.6) | 0.001* |
General symptom | |||
Fatigue | 23.4 (25.9) | 36.4 (26.2) | <0.001* |
Nausea/Vomiting | 4.2 (12.2) | 8.0 (17.4) | 0.04* |
Pain | 16.5 (23.6) | 31.1 (32.7) | <0.001* |
Dyspnea | 12.7 (21.0) | 18.4 (23.7) | 0.04* |
Insomnia | 27.2 (28.2) | 32.0 (30.8) | 0.21 |
Appetite loss | 10.1 (21.1) | 16.1 (25.2) | 0.04* |
Constipation | 8.0 (18.4) | 16.1 (25.6) | 0.004* |
Diarrhea | 8.5 (18.2) | 8.5 (19.2) | 0.97 |
Financial | 17.7 (29.0) | 25.4 (31.6) | 0.09 |